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Abstract: Background: Subdermal contraceptive implants provide safe, effective, convenient, long term reversible 
fertility regulation, and because of their numerous non-contraceptive benefits are particularly suitable for women in 
developing countries. This study determines the socio-demographic characteristics of acceptors of subdermal implants, 
the timing of their use and their complications at the University of Uyo Teaching Hospital, Uyo. 
Materials and Methods: The record cards of all clients that accepted subdermal contraceptive implants over a four year 
period were reviewed. 
Results: There were a total of 1057 new contraceptive acceptors out of which 197 (18.6%) accepted contraceptive 
implants. The modal age group of the clients was 30-34 years (38.0%). One hundred and fifty six patients (79.2%) were 
mulitparous, 97.5% of the patients had attained secondary level of education while 92.4% were Christians. About 56.9% 
of the clients preferred to use implants to space child births, most of the implants were inserted during the first week of 
the menstrual period, and majority (78.2%) of the clients obtained their information concerning implants from clinic 
personnel. The most common complication was abnormal vaginal bleeding. 
Conclusion: contraceptive implants are very effective contraceptive methods that are mostly accepted and used by 
young, educated parous women who mostly preferred to space births. There is also a high continuation rate among 
acceptors so increasing availability of implants in family planning units nationwide could increase the number of women 
who utilize this method of contraception. 
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INTRODUCTION 
Subdermal contraceptive implant development 
began at the population council laboratories in New 
York in 1966 and was made possible by the discovery 
of silicone and its bio-compatibility in the human body 
[1]. Implants provide safe, very effective, convenient, 
long term but reversible fertility regulation [2]. Once 
they are inserted, they require little user compliance or 
motivation, with prompt return of fertility immediately 
after removal of the implants [1]. Though provider 
dependent, their use is private and discrete and allows 
for sexual spontaneity [3].  
Subdermal implants reduce the risk of ectopic 
pregnancy and pelvic inflammatory disease; they 
improve dysmenorrhoea and are devoid of oestrogenic 
side effects hence they can be used by breastfeeding 
mothers and other women who have contraindications 
to oestrogen use [3]. In addition, they have been 
documented to reduce the frequency and severity of 
sickle cell crisis making them suitable for use by 
patients with sickle cell anaemia [4]. They are inserted 
subdermally in the non-dominant upper arm by a 
trained provider. After the production of the first 
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generation implant norplant was stopped due to 
reported difficulties with insertion and removal and its 
use discontinued in most countries [5], the two 
commonly used and available contraceptive implants 
currently are Jadelle and Implanon. 
Jadelle (formerly known as Norplant 2) is developed 
by the Population council and manufactured by Bayer 
Schering Pharma in Finland [5]. It consists of 2 thin 
flexible rods, each 43millmters long and 2.5 millimetres 
wide consisting of a dimethylsiloxane/methylvinylsil- 
oxane copolymer core enclosed in thin walled silicon 
tubing (Figure 1). Each implant contains 75millgrams 
 
 
Figure 1: Jadelle Implants. 
(mg) of the progestogen, levonorgestrel [5]. The 
calculated mean daily in vivo release of levonorgestrel 
is about 100 microgram (ug)/day a month followed by a 
decline and stabilization at 24 months to about 
30ug/day [5]. It is one of the most highly effective 
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contraceptive methods with a Pearl index of 0.2 
pregnancies/100 women years and is effective for 5 
years [5,7]. Its mechanisms of action include inhibition 
of ovulation (in 45%-85% of menstrual cycles), 
thickening of the cervical mucous and suppression of 
endometrial growth. 
Implanon is a single rod contraceptive implant 
developed by Organon Pharmaceutical Company with 
its headquarters in Roseland, New Jersey and was 
launched in 1998 [7]. It is 40mm in length and 2mm in 
width consisting of an ethylene vinylacetate copolymer 
core containing 68mg of the progestogen, etonogestrel 
[6]
 
(Figure 2). Implanon is effective for 3 years, 
although its contraceptive effect may last for up to 4 
years [7]. It is silicon free and releases about 60-70ug 
of etonogestrel initially reducing to 25-30ug at the end 
of the third year. It prevents ovulation as its primary 
mechanism of action in most cycles [5]. Implanon also 
increases the viscosity of cervical mucous and alters 
the endometrial lining contributing to its contraceptive 
efficacy. It requires no post insertion follow up and is 
not visible after insertion. 
 
Figure 2: Implanon Implant. 
There are few studies that focus on contraceptive 
implants in Nigeria and since the establishment of the 
family planning unit of the University of Uyo Teaching 
Hospital and the introduction of contraceptive implants 
into the unit (Jadelle in 2009 and implanon in 2011), to 
the best of the knowledge of the authors, there has 
never been any study on contraceptive implants in the 
center. This study was designed to determine the 
socio-demographic characteristics of acceptors of 
subdermal implants, the timing of their use and their 
complications in our center. 
MATERIALS AND METHODS 
This study was conducted at the maternity unit of 
the University of Uyo Teaching Hospital. The university 
of Uyo Teaching hospital, a newly established Federal 
Teaching Hospital is located in Uyo, the capital of Akwa 
Ibom State in the Niger Delta region of Nigeria. The 
state has a population of over 4 million people, is made 
up of 31 local Government areas and is currently the 
highest oil and gas producing state in the country. 
Along with English, the other major tribes are Ibibio, 
Annang, Eket and Oron. The major occupations of the 
people are farming, fishing, trading and crafts making. 
The registration numbers of all clients that accepted 
contraceptive implants between 1st January 2009 and 
31
st
 December 2012 were obtained from the family 
planning register. The record cards of the clients were 
then retrieved through their registration numbers and 
studied. Information abstracted included the socio-
demographic characteristics of the clients, sources of 
referral, type of implant inserted, previous history of 
contraceptive use, reasons for accepting implants and 
complications experienced by the clients. The data 
were analysed using frequency count and percentages. 
RESULTS 
During the period of the study there were a total of 
1057 new contraceptive acceptors out of which 197 
(18.6%) accepted contraceptive implants. One hundred 
and seventy eight (90.3%) of the patients accepted 
jadelle while 19 (9.6%) accepted implanon.  
The patients’ ages ranged from 17 to 50 with modal 
age group of 30-34 years (38.0%). One hundred and 
fifty six patients (79.2%) were mulitparous, 97.5% of 
the patients had attained secondary level of education, 
92.4% were Christians while traders, civil servants and 
professionals constituted 66.0% of the patients in the 
study population (Table 1). 
Sixty nine (35.0%) clients did not desire any more 
children, One hundred and twelve (56.9%) clients 
wanted to space their child births, while 8.1% of the 
clients were not certain why they wanted to use the 
contraceptive method. 
Seventy one (38.0%) clients discontinued other 
contraceptive methods prior to initiating implants. 
Twenty three (11.7%) had used injectable methods of 
contraception previously, 22 (11.2%) discontinued oral 
contraceptive pills, 20 (10.1%) clients changed from 
intrauterine contraceptive devices, 3 (1.5%) were using 
barrier methods, while 1(0.5%) client changed from 
norplant implants she had inserted previously.  
Most of the implants were inserted during the first  
5-7 days of the menstrual cycle and there were no 
postabortal or puerperal insertions. 
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Table 1: Sociodemographic Characteristics of the 
Clients 
Variable  No (%) 
Age (years)   
15-19  7 (3.6) 
20-24   14 (8.9) 
25-29  49 (24.9) 
30-34  72 (38.1) 
35-39  39 (14.7) 
40-44  11 (5.6) 
44  4 (2.0) 
Not recorded  1 (0.5 
Educational level  
Primary  19 (9.6) 
Secondary  173 (87.8) 
Tertiary  3 (1.5) 
None  2 (0.5) 
Parity  
Po  8 (4.1) 
P1-4  151 (76.6) 
 P5  36 (18.3) 
Not recorded  2 (1.0) 
Occupation  
Trader  59 (30.1) 
Civil servant  50 (23.4) 
Unemployed  16 (8.1) 
Professional  21 (10.7) 
Famer  10 (5.1) 
Hairdresser  8 (4.1) 
Missionary  8 (4.1) 
House wife  6 (3.0) 
Student  4 (2.0) 
Not recorded  4 (2.0) 
 
The majority (78.2%) of the clients obtained 
information concerning the contraceptive method from 
clinic personnel, 13.2% obtained theirs from 
friends/relatives, while 1.5% of the clients got their 
information concerning implants from the print media 
(Table 2). 
Complications occurred in 5.1% of the clients. The 
most common complication was abnormal vaginal 
bleeding in 1.5% of the clients, while dyperunia, 
mucuoid vaginal discharge, vomiting, abdominal pain, 
headache and chest pain were the other complications 
that occurred in 0.5% each of the clients respectively 
(Table 3). There were no accidental pregnancies 
recorded. Only two (1.02%) women discontinued 
implants during the period of the study. 
Table 2: Sources of Information on Contraception 
Source  No (%) 
Clinic personnel  154 (78.2) 
Friends/relatives  26 (13.2) 
Radio  7 (3.6) 
Community Health worker  5 (2.5) 
Print media  3 (1.5) 
Not recorded  2 (1.0) 
 
Table 3: Complications 
Complication No (%) 
Irregular vaginal bleeding 4 (2.0) 
Dysparunia 1 (0.5)  
Mucoid vaginal discharge 1 (0.5) 
Vomiting 1 (0.5) 
Abdominal pains 1 (0.5) 
Headache 1 (0.5) 
Chest pain 1 (0.5) 
DISCUSSION 
Jadelle and Implanon have fewer rods which makes 
them easier to insert and remove than older 
contraceptive implants. However, the number of 
women who accepted and used this method during the 
study period was quite small. This may be due to the 
fact that implants were only recently introduced in the 
state. This finding is however similar to what was 
obtained in Jos, Nigeria where in spite of the fact that 
implants were introduced there over 2 decades earlier, 
the acceptance rate was relatively low [8]. The number 
of clients that accepted Jadelle were more due to its 
earlier introduction and hence availability in the family 
planning unit. 
In spite of the over 25 years of development, 
refinement and introduction of implants in family 
planning programs around the world, the level of 
contraceptive implant use is reportedly low worldwide 
with an estimated use of only 0.2% [5]. The highest 
barrier to implant use is reported to be the high cost of 
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the method in addition to shortage of implants and 
equipments for insertion [5]. Program cost of training 
and retraining providers with insertion and removal 
skills and the time involved in insertion and removal 
also contribute to the high cost of implants [9]. The 
relatively high cost of implants has prevented 
widespread provision of implants in resource poor 
countries [10].  
More than one third of the clients in this study were 
in their early thirties, most were mutltiparous and had at 
least secondary level education. This is similar to what 
was documented from a research conducted in Jos 
Nigeria [8]
 
where the average age of women who 
accepted implanon was 32.4 years and in Malaysia 
[11], where the mean age of Implanon users was 34.7 
years.  
In contrast to results from some studies [6,11] 
where there were no adolescent acceptors, 3.5% of the 
clients in this study population were adolescents. In our 
environment, adolescents have been shown to be at 
very high risk of unintended pregnancies, unsafe 
abortion and all its adverse consequences including 
death [12]. Nigerian adolescents often use ineffective 
and unconventional methods of contraception, which 
they obtain from patent medicine dealers and other non 
medical sources [13]. Notwithstanding, adolescents 
have been shown to be an ideal population for the use 
of implants, and the contraceptive CHOICE project [14] 
showed good acceptance and continuation rates 
among adolescents. 
About a third of the patients preferred to use 
implants to limit family size. This is not surprising as 
due to cultural and religious reasons many women are 
very skeptical about using permanent contraceptive 
methods of contraception in Nigeria [15]. The fact that 
over half of the women preferred to space births with 
implants suggests that the method is highly acceptable 
to our women for short term contraceptive purposes in 
our environment. 
More than two thirds of the clients obtained their 
information about implants from the clinic personnel. 
This is similar to results obtained from research in other 
Nigerian centers [16-17] and may explain the low rate 
of use of modern contraceptive methods in general and 
implants in particularly in Nigeria [18].
 
The contribution 
from other non medically related sources such as the 
print and electronic media were very low, and none of 
the clients obtained information from the internet, 
despite the wealth of information that are available from 
that source in modern times. In Nigeria, apart from 
medical personnel, there is very low knowledge of 
contraceptive implants among the general populace 
[19] as contraceptive methods are hardly discussed in 
vehicles of information including the print and electronic 
media. 
Complications were recorded in 5.1% of the clients 
and out of these 2.0% had irregular vaginal bleeding 
which has been recognized as be the most common 
side effect of contraceptive implants and also their 
greatest drawback [5,7]. About 50-60% of implant 
users have been documented to report irregular vaginal 
bleeding patterns during the first year of use [20]; 
however spontaneous resolution is generally observed 
in subsequent years of usage. Preinsertion counseling 
about menstrual disturbances therefore is important 
prior to insertion of implants and this has been shown 
to increase continuation rates because the known 
advantages far outweigh the nuisance effects [21]. 
Other common side effects reported to follow insertion 
of implants include insertion complications, weight gain, 
ovarian cysts, acne and headaches [3]. Similarly, these 
also resolve with continued usage [7]. 
There were no accidental pregnancies recorded in 
this study. This is similar to what obtains in some other 
studies [8,11]
 
and is a reflection of the high 
effectiveness of this method of contraception. Jadelle 
has a failure rate of 0.2% [5], while implanon is 
reported to be the most effective long acting reversible 
method of contraception available with a failure rate of 
only 0.05% which makes it more effective than female 
sterilization [3]. 
There was a high continuation rate as only 1.02% of 
the women discontinued the method. Studies have 
shown that women who use implants tend to be 
satisfied with the method and continuation rates remain 
high [22]. A recent Cochrane review found that the 
majority who used contraceptive implants continued 
with the method on a long term basis [5].  
Nexplanon, a single rod subdermal implant 
containing 68mg of etonogestrel has been developed. 
It is almost identical to implanon except that it has 
15mg of barium sulphate added to its core [23]. In 
addition, it also has a redesigned preloaded applicator 
for easier insertion. Nexplanon was developed to 
eliminate the problem of non-insertion and localization 
of implanon by changing the inserter device and 
making the rod radiopaque [23]. Nexplanon is widely 
available in the developed world and has even 
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replaced implanon in some countries. However, its 
availability in Nigeria and other developing countries is 
being eagerly awaited. 
In conclusion, contraceptive implants are very 
effective contraceptive methods that are mostly 
accepted and used by young, educated parous women 
who mostly preferred to space births. There is also a 
high continuation rate among acceptors so increasing 
availability of implants in family planning units 
nationwide could increase the number of women who 
utilize this method of contraception. 
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